当前位置: X-MOL 学术Drug. Discov. Today › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Fsp3: A new parameter for drug-likeness.
Drug Discovery Today ( IF 7.4 ) Pub Date : 2020-07-24 , DOI: 10.1016/j.drudis.2020.07.017
Wenxiu Wei 1 , Srinivasulu Cherukupalli 1 , Lanlan Jing 1 , Xinyong Liu 1 , Peng Zhan 1
Affiliation  

The drug-likeness of a compound is a key factor during the initial phases of drug discovery. It can be defined as the similarity between compounds and drugs. Here, we collate research related to the fraction of sp3 carbon atoms (Fsp3), including related high-throughput screening (HTS) cases, structural modifications based on Fsp3, and strategies to improve it. We also introduce new synthetic methods for spirocyclic scaffolds. It is likely that the reasonable rigidity of spirocyclic scaffolds will provide a new generation of drug candidates.



中文翻译:

Fsp3:药物相似性的新参数。

化合物的药物相似性是药物发现初始阶段的关键因素。它可以定义为化合物和药物之间的相似性。在这里,我们整理了与sp 3碳原子分数(Fsp 3)相关的研究,包括相关的高通量筛选(HTS)案例、基于Fsp 3的结构修改以及改进策略。我们还介绍了螺环支架的新合成方法。螺环支架的合理刚性很可能会提供新一代的候选药物。

更新日期:2020-07-24
down
wechat
bug